The use of sodium benzoate in a ten-fold overdose of asparaginase

Paediatric and Perinatal Drug Therapy

Volumn 5, Issue 2, 2002, Pages 59-64

  Doloy, A ^a   Roy, S ^a   Djoussa Kambou, S ^a   Legrand, F ^a   Brion, F ^a   Rieutord, A ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Asparaginase; Hyperammonaemia; Overdose; Sodium benzoate

Indexed keywords

AMMONIA; ASPARAGINASE; BENZOIC ACID; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROCORTISONE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMMONIA BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; BIOCHEMISTRY; CANCER CHEMOTHERAPY; CASE REPORT; DRUG OVERDOSE; HEMODYNAMICS; HUMAN; HYPERAMMONEMIA; MALE; PRESCHOOL CHILD; PROTEIN RESTRICTION; REMISSION;

EID: 0036443652     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300902322125839     Document Type: Article

References (19)

1. Mathias RS, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: Role of nephrologist. Am J Kidney Dis 2001; 37: 1069-1080.
2. Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: A neglected iatrogenic disease in pediatrics. Pediatrics 1986; 77: 848-849.
3. Koren G, Haslam RH. Pediatric medication errors: Predicting and preventing tenfold disasters. J Clin Pharmacol 1994; 34: 1043-1045.
4. The Complete Drug Reference. In: Parfitt K, editor. Martindale. 32th Ed. London: The Pharmaceutical Press; 1999.
5. Broome JD. Evidence that the L-asparaginase activity of guinea pig serum is responsible for antilymphoma effects. Nature 1961; 191: 1114-1115.
6. th ed. Paris: Latour. JF: 2001.p. 105.
7. Holle L M. Pegasparase: An alternative? Ann Pharmacother 1997; 31: 616-624.
8. Haskell CM, Canellos G P, Leventhal BG, et al. L-asparaginase: Therapeutic and toxic effects in patients with neoplasic disease. N Engl J Med 1969; 281: 1028-1034.
9. Feillet F, Leonard JV. Alternative pathway therapy for urea cycle disorders. J Inher Metab Disp 1998; 21: 101-111.
10. Frere P, Canivet JL, Gennigens C, et al. Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 2000; 26: 343-345.
11. Winter SS, Rose E, Katz R. Hyperammonemia after chemotherapy in an adolescent with hepatocellular carcinoma. J Pediatr Gastr Nutr 1997; 25: 537-540.
12. Stevenard M, Lamonier M. Asparagine. Rev Fr Etud Clin Biol 1968: 13: 229-235.
13. Barr J, Eshel G, Chen-Levy Z, Lahat E. Heliox use in the treatment of acute hyperammonemia. J Child Neurol 2001; 16: 456-457.
14. The urea cycle disorders conference group. Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr Gastr Nutr 2001; 138: S1-S5.
15. Leonard JV, Kay JDS. Acute encephalopathy and hyperammonemia complicating treatment of acute lymphoblastic leukaemia with asparaginase. Lancet 1986; 18: 162-163.
16. Rosario MD, Werlin SL, Lauer SJ. Hyperammonemic encephalopathy after chemotherapy. J Clin Gastroenterol 1997; 25: 682-684
17. Praphanphoj V, Boyadjev SA, Waber LJ, Brusilow SW, Geraghty MT. Three cases of intravenous sodium benzoate and sodium phenyacetate toxicity occurring in the treatment of acute hyperammonemia. J Inher Metab Dis 2000; 23: 129-136.
18. Sallan SE, Hitchcock-Bryan S, Gelber R, et al. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukaemia. Cancer Res 1983; 43: 5601-5607.
19. Cohen R, Blanchard N, Frederico F, et al. Draft guidelines for preventing medication errors in paediatrics. J Ped Pharm Practice 1998; 3: 189-202.